Cargando…

Mitochonic Acid-5 Inhibits Reactive Oxygen Species Production and Improves Human Chondrocyte Survival by Upregulating SIRT3-Mediated, Parkin-dependent Mitophagy

Mitochondrial dysfunction is related to the pathogenesis of osteoarthritis (OA); however, there are no effective drugs to treat OA for maintaining mitochondrial homeostasis. Studies have shown that mitochonic acid-5 (MA-5) has a protective effect against mitochondrial damage and plays a role in mito...

Descripción completa

Detalles Bibliográficos
Autores principales: Xin, Ruobing, Xu, Yiyang, Long, Dianbo, Mao, Guping, Liao, Hongyi, Zhang, Ziji, Kang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207248/
https://www.ncbi.nlm.nih.gov/pubmed/35734404
http://dx.doi.org/10.3389/fphar.2022.911716
_version_ 1784729479001669632
author Xin, Ruobing
Xu, Yiyang
Long, Dianbo
Mao, Guping
Liao, Hongyi
Zhang, Ziji
Kang, Yan
author_facet Xin, Ruobing
Xu, Yiyang
Long, Dianbo
Mao, Guping
Liao, Hongyi
Zhang, Ziji
Kang, Yan
author_sort Xin, Ruobing
collection PubMed
description Mitochondrial dysfunction is related to the pathogenesis of osteoarthritis (OA); however, there are no effective drugs to treat OA for maintaining mitochondrial homeostasis. Studies have shown that mitochonic acid-5 (MA-5) has a protective effect against mitochondrial damage and plays a role in mitophagy. However, it is not clear whether MA-5 has a beneficial effect on inflammatory articular cartilage. Here, human OA cartilage was obtained from patients undergoing total joint replacement. Interleukin-1β (IL-1β) was used to stimulate chondrocytes and induce inflammatory injury. Cell Counting Kit-8, TUNEL, and flow cytometry assays were used to assess apoptosis. Gene expression was examined using quantitative reverse transcription-polymerase chain reaction. Mitochondrial function was evaluated using immunoblotting, mitochondrial membrane potential assay, JC-1 staining, and immunofluorescence analysis. Mitophagy was detected using immunoblotting and immunofluorescence. 3-(1H-1,2,3-triazol-4-yl) pyridine (3-TYP), a specific inhibitor of Sirtuin 3 (SIRT3), was used to block the SIRT3/Parkin pathway. Mitophagy in the cartilage sections was evaluated via immunohistochemistry. IL-1β was found to induce chondrocyte apoptosis by inhibiting SIRT3 expression and mitophagy. In addition, inflammatory damage reduced the mitochondrial membrane potential and promoted the production of intracellular reactive oxygen species (ROS), leading to increased mitochondrial division, mitochondrial fusion inhibition, and the consequent mitochondrial damage. In contrast, the MA-5 treatment inhibited excessive ROS production by upregulating mitophagy, maintaining the mitochondrial membrane potential, and reducing mitochondrial apoptosis. After chemically blocking SIRT3 with 3-TYP, Parkin-related mitophagy was also inhibited, an effect that was prevented by pretreatment of the chondrocytes with MA-5, thereby suggesting that SIRT3 is upstream of Parkin. Overall, MA-5 was found to enhance the activity of SIRT3, promote Parkin-dependent mitophagy, eliminate depolarized/damaged mitochondria in chondrocytes, and protect cartilage cells. In conclusion, MA-5 inhibits IL-1β-induced oxidative stress and protects chondrocytes by upregulating the SIRT3/Parkin-related autophagy signaling pathway.
format Online
Article
Text
id pubmed-9207248
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92072482022-06-21 Mitochonic Acid-5 Inhibits Reactive Oxygen Species Production and Improves Human Chondrocyte Survival by Upregulating SIRT3-Mediated, Parkin-dependent Mitophagy Xin, Ruobing Xu, Yiyang Long, Dianbo Mao, Guping Liao, Hongyi Zhang, Ziji Kang, Yan Front Pharmacol Pharmacology Mitochondrial dysfunction is related to the pathogenesis of osteoarthritis (OA); however, there are no effective drugs to treat OA for maintaining mitochondrial homeostasis. Studies have shown that mitochonic acid-5 (MA-5) has a protective effect against mitochondrial damage and plays a role in mitophagy. However, it is not clear whether MA-5 has a beneficial effect on inflammatory articular cartilage. Here, human OA cartilage was obtained from patients undergoing total joint replacement. Interleukin-1β (IL-1β) was used to stimulate chondrocytes and induce inflammatory injury. Cell Counting Kit-8, TUNEL, and flow cytometry assays were used to assess apoptosis. Gene expression was examined using quantitative reverse transcription-polymerase chain reaction. Mitochondrial function was evaluated using immunoblotting, mitochondrial membrane potential assay, JC-1 staining, and immunofluorescence analysis. Mitophagy was detected using immunoblotting and immunofluorescence. 3-(1H-1,2,3-triazol-4-yl) pyridine (3-TYP), a specific inhibitor of Sirtuin 3 (SIRT3), was used to block the SIRT3/Parkin pathway. Mitophagy in the cartilage sections was evaluated via immunohistochemistry. IL-1β was found to induce chondrocyte apoptosis by inhibiting SIRT3 expression and mitophagy. In addition, inflammatory damage reduced the mitochondrial membrane potential and promoted the production of intracellular reactive oxygen species (ROS), leading to increased mitochondrial division, mitochondrial fusion inhibition, and the consequent mitochondrial damage. In contrast, the MA-5 treatment inhibited excessive ROS production by upregulating mitophagy, maintaining the mitochondrial membrane potential, and reducing mitochondrial apoptosis. After chemically blocking SIRT3 with 3-TYP, Parkin-related mitophagy was also inhibited, an effect that was prevented by pretreatment of the chondrocytes with MA-5, thereby suggesting that SIRT3 is upstream of Parkin. Overall, MA-5 was found to enhance the activity of SIRT3, promote Parkin-dependent mitophagy, eliminate depolarized/damaged mitochondria in chondrocytes, and protect cartilage cells. In conclusion, MA-5 inhibits IL-1β-induced oxidative stress and protects chondrocytes by upregulating the SIRT3/Parkin-related autophagy signaling pathway. Frontiers Media S.A. 2022-06-06 /pmc/articles/PMC9207248/ /pubmed/35734404 http://dx.doi.org/10.3389/fphar.2022.911716 Text en Copyright © 2022 Xin, Xu, Long, Mao, Liao, Zhang and Kang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Xin, Ruobing
Xu, Yiyang
Long, Dianbo
Mao, Guping
Liao, Hongyi
Zhang, Ziji
Kang, Yan
Mitochonic Acid-5 Inhibits Reactive Oxygen Species Production and Improves Human Chondrocyte Survival by Upregulating SIRT3-Mediated, Parkin-dependent Mitophagy
title Mitochonic Acid-5 Inhibits Reactive Oxygen Species Production and Improves Human Chondrocyte Survival by Upregulating SIRT3-Mediated, Parkin-dependent Mitophagy
title_full Mitochonic Acid-5 Inhibits Reactive Oxygen Species Production and Improves Human Chondrocyte Survival by Upregulating SIRT3-Mediated, Parkin-dependent Mitophagy
title_fullStr Mitochonic Acid-5 Inhibits Reactive Oxygen Species Production and Improves Human Chondrocyte Survival by Upregulating SIRT3-Mediated, Parkin-dependent Mitophagy
title_full_unstemmed Mitochonic Acid-5 Inhibits Reactive Oxygen Species Production and Improves Human Chondrocyte Survival by Upregulating SIRT3-Mediated, Parkin-dependent Mitophagy
title_short Mitochonic Acid-5 Inhibits Reactive Oxygen Species Production and Improves Human Chondrocyte Survival by Upregulating SIRT3-Mediated, Parkin-dependent Mitophagy
title_sort mitochonic acid-5 inhibits reactive oxygen species production and improves human chondrocyte survival by upregulating sirt3-mediated, parkin-dependent mitophagy
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207248/
https://www.ncbi.nlm.nih.gov/pubmed/35734404
http://dx.doi.org/10.3389/fphar.2022.911716
work_keys_str_mv AT xinruobing mitochonicacid5inhibitsreactiveoxygenspeciesproductionandimproveshumanchondrocytesurvivalbyupregulatingsirt3mediatedparkindependentmitophagy
AT xuyiyang mitochonicacid5inhibitsreactiveoxygenspeciesproductionandimproveshumanchondrocytesurvivalbyupregulatingsirt3mediatedparkindependentmitophagy
AT longdianbo mitochonicacid5inhibitsreactiveoxygenspeciesproductionandimproveshumanchondrocytesurvivalbyupregulatingsirt3mediatedparkindependentmitophagy
AT maoguping mitochonicacid5inhibitsreactiveoxygenspeciesproductionandimproveshumanchondrocytesurvivalbyupregulatingsirt3mediatedparkindependentmitophagy
AT liaohongyi mitochonicacid5inhibitsreactiveoxygenspeciesproductionandimproveshumanchondrocytesurvivalbyupregulatingsirt3mediatedparkindependentmitophagy
AT zhangziji mitochonicacid5inhibitsreactiveoxygenspeciesproductionandimproveshumanchondrocytesurvivalbyupregulatingsirt3mediatedparkindependentmitophagy
AT kangyan mitochonicacid5inhibitsreactiveoxygenspeciesproductionandimproveshumanchondrocytesurvivalbyupregulatingsirt3mediatedparkindependentmitophagy